Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by IncoproHosted by Managing IP’s Ed Conlon, the discussion at Incopro’s Insync Virtual Summit explored how the pandemic has affected brand protection teams and offered key insights to drive success in 2021 -
Sponsored by Januar Jahja & PartnersAndrew Diamond and Fabiola Rossy of Januar Jahja and Partners take a closer look at the recent trademark battle between two large oral care brands
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners looks at a recent judicial decision concerning the Antimonopoly Act and considers the growing litigation of this area in Japan
-
Sponsored by AnJie Law FirmLi Wu of AnJie Law Firm explains how the administrative and judicial sectors are slowly embracing a more favourable stance towards the acceptance of post-filing supplementary data
-
Sponsored by Griffith HackRobert Wulff and Arun Nagasubramanian of Griffith Hack analyse patent filings statistics to assess Australian and global progress towards building a hydrogen-fuelled economy
-
Sponsored by Bird & BirdRichard Vary of Bird & Bird explains why Wuhan has become a destination jurisdiction of anti-suit injunctions and looks at the challenges that implementers face
